Who is eligible for clinical trial NCT06732596?

Participants must meet protocol criteria for Opioid Use Disorder. Confirm exact inclusion and exclusion requirements with the study coordinator.

Does clinical trial NCT06732596 provide travel or cost reimbursement?

Check with the site coordinator at the participating facility for travel and lodging stipend availability, and for which routine-care costs are covered.

🏛️ Verified NIH Record • Updated 2025-10-30

Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents (NCT06732596)

🟢 Recruiting Observational / Diagnostic 📋 Clinical Research Protocol Sponsor: Boston Medical Center

🩺 Plain-English Summary (8th-Grade Level)

This study aims to improve retention in buprenorphine treatment, a medication used for opioid use disorder, through the use of a smartphone-delivered recovery support intervention. The intervention involves an Embodied Conversational Agent (ECA), a virtual, animated computer agent designed to simulate natural face-to-face conversations. ECAs have been shown to help individuals manage their healthcare in other settings, and this study seeks to evaluate their potential in supporting patients on medication for opioid use disorder (MOUD).

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (7 items) and avoid the listed exclusions (4 items).

Location: Office-Based Addiction Treatment (OBAT) Clinic, BMC — Boston, Massachusetts

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

Diagnosis of Opioid Use Disorder (OUD)
Within 30 days of intake at recruitment site (BMC OBAT)
Possession of a smartphone that has minimum requirements
English-speaking and reading
Willing to release electronic health record (EHR) data
Able to provide at least two alternate contacts who usually know how to get in touch with them
Currently prescribed buprenorphine from an outpatient clinic

Usually NOT eligible if any of the following apply:

Exclusion Criteria:
Incarceration anticipated within 12 months of enrollment
Inability to comprehend the study protocol, defined as failing three times to answer correctly a set of questions during the consent process
Inability to use the ECA app (i.e., due to markedly limited visual or auditory acuity or motor function required to interact with the ECA)

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (1 Sites)

Office-Based Addiction Treatment (OBAT) Clinic, BMC — Boston, Massachusetts

💰 Cost, Insurance & Patient Rights

100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

🏛️ View Official NIH Record ↗